Cargando…
_version_ 1784686856379564032
author Ozierański, Krzysztof
Tymińska, Agata
Marchel, Michal
Januszkiewicz, Łukasz
Maciejewski, Cezary
Główczyńska, Renata
Marcolongo, Renzo
Caforio, Alida L.P.
Wojnicz, Romuald
Mizia-Stec, Katarzyna
Grzybowski, Jacek
Gąsior, Mariusz
Nowalany-Kozielska, Ewa
Pawlak, Agnieszka
Kaczmarek, Krzysztof
Żegarska, Jolanta
Pączek, Leszek
Balsam, Paweł
Opolski, Grzegorz
Grabowski, Marcin
author_facet Ozierański, Krzysztof
Tymińska, Agata
Marchel, Michal
Januszkiewicz, Łukasz
Maciejewski, Cezary
Główczyńska, Renata
Marcolongo, Renzo
Caforio, Alida L.P.
Wojnicz, Romuald
Mizia-Stec, Katarzyna
Grzybowski, Jacek
Gąsior, Mariusz
Nowalany-Kozielska, Ewa
Pawlak, Agnieszka
Kaczmarek, Krzysztof
Żegarska, Jolanta
Pączek, Leszek
Balsam, Paweł
Opolski, Grzegorz
Grabowski, Marcin
author_sort Ozierański, Krzysztof
collection PubMed
description
format Online
Article
Text
id pubmed-9007472
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Via Medica
record_format MEDLINE/PubMed
spelling pubmed-90074722022-04-14 A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC) Ozierański, Krzysztof Tymińska, Agata Marchel, Michal Januszkiewicz, Łukasz Maciejewski, Cezary Główczyńska, Renata Marcolongo, Renzo Caforio, Alida L.P. Wojnicz, Romuald Mizia-Stec, Katarzyna Grzybowski, Jacek Gąsior, Mariusz Nowalany-Kozielska, Ewa Pawlak, Agnieszka Kaczmarek, Krzysztof Żegarska, Jolanta Pączek, Leszek Balsam, Paweł Opolski, Grzegorz Grabowski, Marcin Cardiol J Clinical Cardiology Via Medica 2022-04-07 /pmc/articles/PMC9007472/ /pubmed/34897632 http://dx.doi.org/10.5603/CJ.a2021.0166 Text en Copyright © 2022 Via Medica https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially
spellingShingle Clinical Cardiology
Ozierański, Krzysztof
Tymińska, Agata
Marchel, Michal
Januszkiewicz, Łukasz
Maciejewski, Cezary
Główczyńska, Renata
Marcolongo, Renzo
Caforio, Alida L.P.
Wojnicz, Romuald
Mizia-Stec, Katarzyna
Grzybowski, Jacek
Gąsior, Mariusz
Nowalany-Kozielska, Ewa
Pawlak, Agnieszka
Kaczmarek, Krzysztof
Żegarska, Jolanta
Pączek, Leszek
Balsam, Paweł
Opolski, Grzegorz
Grabowski, Marcin
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)
title A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)
title_full A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)
title_fullStr A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)
title_full_unstemmed A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)
title_short A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)
title_sort multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (improve-mc)
topic Clinical Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007472/
https://www.ncbi.nlm.nih.gov/pubmed/34897632
http://dx.doi.org/10.5603/CJ.a2021.0166
work_keys_str_mv AT ozieranskikrzysztof amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT tyminskaagata amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT marchelmichal amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT januszkiewiczłukasz amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT maciejewskicezary amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT głowczynskarenata amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT marcolongorenzo amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT caforioalidalp amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT wojniczromuald amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT miziasteckatarzyna amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT grzybowskijacek amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT gasiormariusz amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT nowalanykozielskaewa amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT pawlakagnieszka amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT kaczmarekkrzysztof amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT zegarskajolanta amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT paczekleszek amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT balsampaweł amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT opolskigrzegorz amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT grabowskimarcin amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT ozieranskikrzysztof multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT tyminskaagata multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT marchelmichal multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT januszkiewiczłukasz multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT maciejewskicezary multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT głowczynskarenata multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT marcolongorenzo multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT caforioalidalp multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT wojniczromuald multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT miziasteckatarzyna multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT grzybowskijacek multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT gasiormariusz multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT nowalanykozielskaewa multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT pawlakagnieszka multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT kaczmarekkrzysztof multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT zegarskajolanta multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT paczekleszek multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT balsampaweł multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT opolskigrzegorz multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc
AT grabowskimarcin multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc